Use of antidiabetics for making a medicine with cicatrizing effect
First Claim
Patent Images
1. The use of at least one antidiabetic chosen from compounds stimulating the secretion of insulin, glucosidase inhibitors, thiazolidinediones, insulin, agents enhancing sensitivity to insulin, glucagon-like peptide-1 (GLP-1), PPAR α
- /γ
agonists, meglitinide and aP2 inhibitors, for manufacturing a medicine having a cicatrizing effect.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention concerns the use of at least an antidiabetic selected among compounds stimulation insulin secretion, glucosidase inhibitors, thiazolidine-diones, insulin, agents enhancing insulin sensitivity, the glucagon-like peptide-1 (GLP-1), PPARα/γ agonists, meglitinide and aP2 inhibitors for making a medicine with cicatrizing effect.
-
Citations
11 Claims
-
1. The use of at least one antidiabetic chosen from compounds stimulating the secretion of insulin, glucosidase inhibitors, thiazolidinediones, insulin, agents enhancing sensitivity to insulin, glucagon-like peptide-1 (GLP-1), PPAR α
- /γ
agonists, meglitinide and aP2 inhibitors, for manufacturing a medicine having a cicatrizing effect. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- /γ
Specification